United States Prescription Dermatological Drug Industry 2016 Deep Market Research Report
- QYR604699
- 138 Pages
- June 2016
- Pharmaceuticals
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Prescription Dermatological Drug market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Prescription Dermatological Drug industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 155 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview
1.1 Definition and Specifications of Prescription Dermatological Drug
1.1.1 Definition of Prescription Dermatological Drug
1.1.2 Specifications of Prescription Dermatological Drug
1.2 Classification of Prescription Dermatological Drug
1.3 Applications of Prescription Dermatological Drug
1.4 Industry Chain Structure of Prescription Dermatological Drug
1.5 Industry Overview of Prescription Dermatological Drug
1.6 Industry Policy Analysis of Prescription Dermatological Drug
1.7 Industry News Analysis of Prescription Dermatological Drug
2 Manufacturing Cost Structure Analysis of Prescription Dermatological Drug
2.1 Bill of Materials (BOM) of Prescription Dermatological Drug
2.2 BOM Price Analysis of Prescription Dermatological Drug
2.3 Labor Cost Analysis of Prescription Dermatological Drug
2.4 Depreciation Cost Analysis of Prescription Dermatological Drug
2.5 Manufacturing Cost Structure Analysis of Prescription Dermatological Drug
2.6 Manufacturing Process Analysis of Prescription Dermatological Drug
2.7 United States Price, Cost and Gross of Prescription Dermatological Drug 2011-2016
3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015
3.2 Manufacturing Plants Distribution of United States Key Prescription Dermatological Drug Manufacturers in 2015
3.3 R&D Status and Technology Source of United States Prescription Dermatological Drug Key Manufacturers in 2015
3.4 Raw Materials Sources Analysis of United States Prescription Dermatological Drug Key Manufacturers in 2015
4 Production Analysis of Prescription Dermatological Drug by Regions, Type, and Applications
4.1 United States Production of Prescription Dermatological Drug by Regions 2011-2016
4.2 United States Production of Prescription Dermatological Drug by Type 2011-2016
4.3 United States Sales of Prescription Dermatological Drug by Applications 2011-2016
4.4 Price Analysis of United States Prescription Dermatological Drug Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Prescription Dermatological Drug 2011-2016
5 Consumption Volume and Consumption Value Analysis of Prescription Dermatological Drug by Regions
5.1 United States Consumption Volume of Prescription Dermatological Drug by Regions 2011-2016
5.2 United States Consumption Value of Prescription Dermatological Drug by Regions 2011-2016
5.3 United States Consumption Price Analysis of Prescription Dermatological Drug by Regions 2011-2016
6 Analysis of Prescription Dermatological Drug Production, Supply, Sales and Market Status 2011-2016
6.1 Capacity, Production, Sales, and Revenue of Prescription Dermatological Drug 2011-2016
6.2 Production Market Share and Sales Market Share Analysis of Prescription Dermatological Drug 2014-2015
6.3 Sales Overview of Prescription Dermatological Drug 2011-2016
6.4 Supply, Consumption and Gap of Prescription Dermatological Drug 2011-2016
6.5 Import, Export and Consumption of Prescription Dermatological Drug 2011-2016
6.6 Cost, Price, Revenue and Gross Margin of Prescription Dermatological Drug 2011-2016
7 Analysis of Prescription Dermatological Drug Industry Key Manufacturers
7.1 Allergan Inc.
7.1.1 Company Profile
7.1.2 Product Picture and Specifications
7.1.2.1 Type I
7.1.2.2 Type II
7.1.2.3 Type III
7.1.3 Capacity, Production, Price, Cost, Gross and Revenue
7.1.4 Contact Information
7.2 Allergan Inamed Corporation
7.2.1 Company Profile
7.2.2 Product Picture and Specifications
7.2.2.1 Type I
7.2.2.2 Type II
7.2.2.3 Type III
7.2.3 Capacity, Production, Price, Cost, Gross and Revenue
7.2.4 Contact Information
7.3 Barrier Therapeutics, Inc
7.3.1 Company Profile
7.3.2 Product Picture and Specifications
7.3.2.1 Type I
7.3.2.2 Type II
7.3.2.3 Type III
7.3.3 Capacity, Production, Price, Cost, Gross and Revenue
7.3.4 Contact Information
7.4 Bayer AG
7.4.1 Company Profile
7.4.2 Product Picture and Specifications
7.4.2.1 Type I
7.4.2.2 Type II
7.4.2.3 Type III
7.4.3 Capacity, Production, Price, Cost, Gross and Revenue
7.4.4 Contact Information
7.5 PharmaDerm Pharmaceuticals, Inc
7.5.1 Company Profile
7.5.2 Product Picture and Specifications
7.5.2.1 Type I
7.5.2.2 Type II
7.5.2.3 Type III
7.5.3 Capacity, Production, Price, Cost, Gross and Revenue
7.5.4 Contact Information
7.6 Bristol-Myers Squibb
7.6.1 Company Profile
7.6.2 Product Picture and Specifications
7.6.2.1 Type I
7.6.2.2 Type II
7.6.2.3 Type III
7.6.3 Capacity, Production, Price, Cost, Gross and Revenue
7.6.4 Contact Information
7.7 Collagenex (now Galderma) Pharmaceuticals
7.7.1 Company Profile
7.7.2 Product Picture and Specifications
7.7.2.1 Type I
7.7.2.2 Type II
7.7.2.3 Type III
7.7.3 Capacity, Production, Price, Cost, Gross and Revenue
7.7.4 Contact Information
7.8 Galderma S.A.
7.8.1 Company Profile
7.8.2 Product Picture and Specifications
7.8.2.1 Type I
7.8.2.2 Type II
7.8.2.3 Type III
7.8.3 Capacity, Production, Price, Cost, Gross and Revenue
7.8.4 Contact Information
7.9 Genentech, Inc.
7.9.1 Company Profile
7.9.2 Product Picture and Specifications
7.9.2.1 Type I
7.9.2.2 Type II
7.9.2.3 Type III
7.9.3 Capacity, Production, Price, Cost, Gross and Revenue
7.9.4 Contact Information
7.10 GlaxoSmithKline Plc
7.10.1 Company Profile
7.10.2 Product Picture and Specifications
7.10.2.1 Type I
7.10.2.2 Type II
7.10.2.3 Type III
7.10.3 Capacity, Production, Price, Cost, Gross and Revenue
7.10.4 Contact Information
7.11 Medicis Pharmaceutical Corporation
7.11.1 Company Profile
7.11.2 Product Picture and Specifications
7.11.2.1 Type I
7.11.2.2 Type II
7.11.2.3 Type III
7.11.3 Capacity, Production, Price, Cost, Gross and Revenue
7.11.4 Contact Information
7.12 Merck & Company, Inc.
7.12.1 Company Profile
7.12.2 Product Picture and Specifications
7.12.2.1 Type I
7.12.2.2 Type II
7.12.2.3 Type III
7.12.3 Capacity, Production, Price, Cost, Gross and Revenue
7.12.4 Contact Information
7.13 Mylan Pharmaceuticals, Inc,
7.13.1 Company Profile
7.13.2 Product Picture and Specifications
7.13.2.1 Type I
7.13.2.2 Type II
7.13.2.3 Type III
7.13.3 Capacity, Production, Price, Cost, Gross and Revenue
7.13.4 Contact Information
7.14 Novartis Pharmaceuticals Corporation
7.14.1 Company Profile
7.14.2 Product Picture and Specifications
7.14.2.1 Type I
7.14.2.2 Type II
7.14.2.3 Type III
7.14.3 Capacity, Production, Price, Cost, Gross and Revenue
7.14.4 Contact Information
7.15 Nycomed Inc.
7.15.1 Company Profile
7.15.2 Product Picture and Specifications
7.15.2.1 Type I
7.15.2.2 Type II
7.15.2.3 Type III
7.15.3 Capacity, Production, Price, Cost, Gross and Revenue
7.15.4 Contact Information
7.16 Pfizer, Inc.
7.16.1 Company Profile
7.16.2 Product Picture and Specifications
7.16.2.1 Type I
7.16.2.2 Type II
7.16.2.3 Type III
7.16.3 Capacity, Production, Price, Cost, Gross and Revenue
7.16.4 Contact Information
8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Prescription Dermatological Drug Product Types
8.5 Market Share Analysis of Different Prescription Dermatological Drug Price Levels
8.6 Gross Margin Analysis of Different Prescription Dermatological Drug Applications
9 Marketing Trader or Distributor Analysis of Prescription Dermatological Drug
9.1 Marketing Channels Status of Prescription Dermatological Drug
9.2 Traders or Distributors of Prescription Dermatological Drug with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Prescription Dermatological Drug
9.4 United States Import, Export and Trade Analysis of Prescription Dermatological Drug
10 Development Trend of Prescription Dermatological Drug Industry 2016-2021
10.1 Capacity and Production Overview of Prescription Dermatological Drug 2016-2021
10.2 Production Market Share by Product Types of Prescription Dermatological Drug 2016-2021
10.3 Sales and Sales Revenue Overview of Prescription Dermatological Drug 2016-2021
10.4 United States Sales of Prescription Dermatological Drug by Applications 2016-2021
10.5 Import, Export and Consumption of Prescription Dermatological Drug 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Prescription Dermatological Drug 2016-2021
11 Industry Chain Suppliers of Prescription Dermatological Drug with Contact Information
11.1 Major Raw Materials Suppliers of Prescription Dermatological Drug with Contact Information
11.2 Manufacturing Equipment Suppliers of Prescription Dermatological Drug with Contact Information
11.3 Major Players of Prescription Dermatological Drug with Contact Information
11.4 Key Consumers of Prescription Dermatological Drug with Contact Information
11.5 Supply Chain Relationship Analysis of Prescription Dermatological Drug
12 New Project Investment Feasibility Analysis of Prescription Dermatological Drug
12.1 New Project SWOT Analysis of Prescription Dermatological Drug
12.2 New Project Investment Feasibility Analysis of Prescription Dermatological Drug
13 Conclusion of the United States Prescription Dermatological Drug Industry 2016 Market Research Report
Figure Picture of Prescription Dermatological Drug
Table Product Specifications of Prescription Dermatological Drug
Table Classification of Prescription Dermatological Drug
Figure United States Sales Market Share of Prescription Dermatological Drug by Product Types in 2015
Table Applications of Prescription Dermatological Drug
Figure United States Sales Market Share of Prescription Dermatological Drug by Applications in 2015
Figure Industry Chain Structure of Prescription Dermatological Drug
Table United States Industry Overview of Prescription Dermatological Drug
Table Industry Policy of Prescription Dermatological Drug
Table Industry News List of Prescription Dermatological Drug
Table Bill of Materials (BOM) of Prescription Dermatological Drug
Table Bill of Materials (BOM) Price of Prescription Dermatological Drug
Table Labor Cost of Prescription Dermatological Drug
Table Depreciation Cost of Prescription Dermatological Drug
Table Manufacturing Cost Structure Analysis of Prescription Dermatological Drug in 2015
Figure Manufacturing Process Analysis of Prescription Dermatological Drug
Table United States Price Analysis of Prescription Dermatological Drug 2011-2016 (USD/Unit)
Table United States Cost Analysis of Prescription Dermatological Drug 2011-2016 (USD/Unit)
Table United States Gross Analysis of Prescription Dermatological Drug 2011-2016
Table Capacity (Unit) and Commercial Production Date of United States Prescription Dermatological Drug Key Manufacturers in 2015
Table Manufacturing Plants Distribution of United States Key Prescription Dermatological Drug Manufacturers in 2015
Table R&D Status and Technology Source of United States Prescription Dermatological Drug Key Manufacturers in 2015
Table Raw Materials Sources Analysis of United States and United States Prescription Dermatological Drug Key Manufacturers in 2015
Table United States Production of Prescription Dermatological Drug by Regions 2011-2016 (Unit)
Table United States Production Market Share of Prescription Dermatological Drug by Regions 2011-2016
Figure United States Production Market Share of Prescription Dermatological Drug by Regions in 2014
Figure United States Production Market Share of Prescription Dermatological Drug by Regions in 2015
Table United States Production of Prescription Dermatological Drug by Types in 2011-2016 (Unit)
Table United States Production Market Share of Prescription Dermatological Drug by Type in 2011-2016
Figure United States Production Market Share of Prescription Dermatological Drug by Type in 2014
Figure United States Production Market Share of Prescription Dermatological Drug by Type in 2015
Table United States Sales of Prescription Dermatological Drug by Applications 2011-2016 (Unit)
Table United States Production Market Share of Prescription Dermatological Drug by Applications 2011-2016
Figure United States Production Market Share of Prescription Dermatological Drug by Applications in 2014
Figure United States Production Market Share of Prescription Dermatological Drug by Applications in 2015
Table Price Comparison of United States Prescription Dermatological Drug Key Manufacturers in 2015 (USD/Unit)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Prescription Dermatological Drug 2011-2016
Table United States Consumption Volume of Prescription Dermatological Drug by Regions 2011-2016 (Unit)
Table United States Consumption Volume Market Share of Prescription Dermatological Drug by Regions 2011-2016
Figure United States Consumption Volume Market Share of Prescription Dermatological Drug by Regions in 2014
Figure United States Consumption Volume Market Share of Prescription Dermatological Drug by Regions in 2015
Table United States Consumption Value of Prescription Dermatological Drug by Regions 2011-2016 (M USD)
Table United States Consumption Value Market Share of Prescription Dermatological Drug by Regions 2011-2016
Figure United States Consumption Value Market Share of Prescription Dermatological Drug by Regions in 2014
Figure United States Consumption Value Market Share of Prescription Dermatological Drug by Regions in 2015
Table Consumption Price of Prescription Dermatological Drug by Regions 2011-2016 (USD/Unit)
Table United States and Major Manufacturers Capacity of Prescription Dermatological Drug 2011-2016 (Unit)
Table United States Capacity Market Share of Major Prescription Dermatological Drug Manufacturers 2011-2016
Table United States and Major Manufacturers Production of Prescription Dermatological Drug 2011-2016 (Unit)
Table United States Production Market Share of Major Prescription Dermatological Drug Manufacturers 2011-2016
Table United States and Major Manufacturers Sales of Prescription Dermatological Drug 2011-2016 (Unit)
Table United States Sales Market Share of Major Prescription Dermatological Drug Manufacturers 2011-2016
Table United States and Major Manufacturers Sales Revenue of Prescription Dermatological Drug 2011-2016 (M USD)
Table United States Sales Revenue Market Share of Major Prescription Dermatological Drug Manufacturers 2011-2016
Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Prescription Dermatological Drug 2011-2016
Figure United States Capacity Utilization Rate of Prescription Dermatological Drug 2011-2016
Figure United States Sales Revenue (M USD) and Growth Rate of Prescription Dermatological Drug 2011-2016
Figure United States Production Market Share of Major Prescription Dermatological Drug Manufacturers in 2014
Figure United States Production Market Share of Major Prescription Dermatological Drug Manufacturers in 2015
Figure United States Sales Market Share of Major Prescription Dermatological Drug Manufacturers in 2014
Figure United States Sales Market Share of Major Prescription Dermatological Drug Manufacturers in 2015
Figure United States Sales (Unit) and Growth Rate of Prescription Dermatological Drug 2011-2016
Table United States Supply, Consumption and Gap of Prescription Dermatological Drug 2011-2016 (Unit)
Table United States Import, Export and Consumption of Prescription Dermatological Drug 2011-2016 (Unit)
Table Price of United States Prescription Dermatological Drug Major Manufacturers 2011-2016 (USD/Unit)
Table Gross Margin of United States Prescription Dermatological Drug Major Manufacturers 2011-2016
Table United States and Major Manufacturers Revenue of Prescription Dermatological Drug 2011-2016 (M USD)
Table United States Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Prescription Dermatological Drug 2011-2016
Table Allergan Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prescription Dermatological Drug Picture and Specifications of Allergan Inc.
Table Prescription Dermatological Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Allergan Inc. 2011-2016
Figure Prescription Dermatological Drug Capacity (Unit), Production (Unit) and Growth Rate of Allergan Inc. 2011-2016
Figure Prescription Dermatological Drug Production (Unit) and United States Market Share of Allergan Inc. 2011-2016
Table Allergan Inc. Prescription Dermatological Drug SWOT Analysis
Table Allergan Inamed Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prescription Dermatological Drug Picture and Specifications of Allergan Inamed Corporation
Table Prescription Dermatological Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Allergan Inamed Corporation 2011-2016
Figure Prescription Dermatological Drug Capacity (Unit), Production (Unit) and Growth Rate of Allergan Inamed Corporation 2011-2016
Figure Prescription Dermatological Drug Production (Unit) and United States Market Share of Allergan Inamed Corporation 2011-2016
Table Allergan Inamed Corporation Prescription Dermatological Drug SWOT Analysis
Table Barrier Therapeutics, Inc Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prescription Dermatological Drug Picture and Specifications of Barrier Therapeutics, Inc
Table Prescription Dermatological Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Barrier Therapeutics, Inc 2011-2016
Figure Prescription Dermatological Drug Capacity (Unit), Production (Unit) and Growth Rate of Barrier Therapeutics, Inc 2011-2016
Figure Prescription Dermatological Drug Production (Unit) and United States Market Share of Barrier Therapeutics, Inc 2011-2016
Table Barrier Therapeutics, Inc Prescription Dermatological Drug SWOT Analysis
Table Bayer AG Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prescription Dermatological Drug Picture and Specifications of Bayer AG
Table Prescription Dermatological Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bayer AG 2011-2016
Figure Prescription Dermatological Drug Capacity (Unit), Production (Unit) and Growth Rate of Bayer AG 2011-2016
Figure Prescription Dermatological Drug Production (Unit) and United States Market Share of Bayer AG 2011-2016
Table Bayer AG Prescription Dermatological Drug SWOT Analysis
Table PharmaDerm Pharmaceuticals, Inc Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prescription Dermatological Drug Picture and Specifications of PharmaDerm Pharmaceuticals, Inc
Table Prescription Dermatological Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of PharmaDerm Pharmaceuticals, Inc 2011-2016
Figure Prescription Dermatological Drug Capacity (Unit), Production (Unit) and Growth Rate of PharmaDerm Pharmaceuticals, Inc 2011-2016
Figure Prescription Dermatological Drug Production (Unit) and United States Market Share of PharmaDerm Pharmaceuticals, Inc 2011-2016
Table PharmaDerm Pharmaceuticals, Inc Prescription Dermatological Drug SWOT Analysis
Table Bristol-Myers Squibb Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prescription Dermatological Drug Picture and Specifications of Bristol-Myers Squibb
Table Prescription Dermatological Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Bristol-Myers Squibb 2011-2016
Figure Prescription Dermatological Drug Capacity (Unit), Production (Unit) and Growth Rate of Bristol-Myers Squibb 2011-2016
Figure Prescription Dermatological Drug Production (Unit) and United States Market Share of Bristol-Myers Squibb 2011-2016
Table Bristol-Myers Squibb Prescription Dermatological Drug SWOT Analysis
Table Collagenex (now Galderma) Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prescription Dermatological Drug Picture and Specifications of Collagenex (now Galderma) Pharmaceuticals
Table Prescription Dermatological Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Collagenex (now Galderma) Pharmaceuticals 2011-2016
Figure Prescription Dermatological Drug Capacity (Unit), Production (Unit) and Growth Rate of Collagenex (now Galderma) Pharmaceuticals 2011-2016
Figure Prescription Dermatological Drug Production (Unit) and United States Market Share of Collagenex (now Galderma) Pharmaceuticals 2011-2016
Table Collagenex (now Galderma) Pharmaceuticals Prescription Dermatological Drug SWOT Analysis
Table Galderma S.A. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prescription Dermatological Drug Picture and Specifications of Galderma S.A.
Table Prescription Dermatological Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Galderma S.A. 2011-2016
Figure Prescription Dermatological Drug Capacity (Unit), Production (Unit) and Growth Rate of Galderma S.A. 2011-2016
Figure Prescription Dermatological Drug Production (Unit) and United States Market Share of Galderma S.A. 2011-2016
Table Galderma S.A. Prescription Dermatological Drug SWOT Analysis
Table Genentech, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prescription Dermatological Drug Picture and Specifications of Genentech, Inc.
Table Prescription Dermatological Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Genentech, Inc. 2011-2016
Figure Prescription Dermatological Drug Capacity (Unit), Production (Unit) and Growth Rate of Genentech, Inc. 2011-2016
Figure Prescription Dermatological Drug Production (Unit) and United States Market Share of Genentech, Inc. 2011-2016
Table Genentech, Inc. Prescription Dermatological Drug SWOT Analysis
Table GlaxoSmithKline Plc Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prescription Dermatological Drug Picture and Specifications of GlaxoSmithKline Plc
Table Prescription Dermatological Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of GlaxoSmithKline Plc 2011-2016
Figure Prescription Dermatological Drug Capacity (Unit), Production (Unit) and Growth Rate of GlaxoSmithKline Plc 2011-2016
Figure Prescription Dermatological Drug Production (Unit) and United States Market Share of GlaxoSmithKline Plc 2011-2016
Table GlaxoSmithKline Plc Prescription Dermatological Drug SWOT Analysis
Table Medicis Pharmaceutical Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prescription Dermatological Drug Picture and Specifications of Medicis Pharmaceutical Corporation
Table Prescription Dermatological Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Medicis Pharmaceutical Corporation 2011-2016
Figure Prescription Dermatological Drug Capacity (Unit), Production (Unit) and Growth Rate of Medicis Pharmaceutical Corporation 2011-2016
Figure Prescription Dermatological Drug Production (Unit) and United States Market Share of Medicis Pharmaceutical Corporation 2011-2016
Table Medicis Pharmaceutical Corporation Prescription Dermatological Drug SWOT Analysis
Table Merck & Company, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prescription Dermatological Drug Picture and Specifications of Merck & Company, Inc.
Table Prescription Dermatological Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Merck & Company, Inc. 2011-2016
Figure Prescription Dermatological Drug Capacity (Unit), Production (Unit) and Growth Rate of Merck & Company, Inc. 2011-2016
Figure Prescription Dermatological Drug Production (Unit) and United States Market Share of Merck & Company, Inc. 2011-2016
Table Merck & Company, Inc. Prescription Dermatological Drug SWOT Analysis
Table Mylan Pharmaceuticals, Inc, Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prescription Dermatological Drug Picture and Specifications of Mylan Pharmaceuticals, Inc,
Table Prescription Dermatological Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Mylan Pharmaceuticals, Inc, 2011-2016
Figure Prescription Dermatological Drug Capacity (Unit), Production (Unit) and Growth Rate of Mylan Pharmaceuticals, Inc, 2011-2016
Figure Prescription Dermatological Drug Production (Unit) and United States Market Share of Mylan Pharmaceuticals, Inc, 2011-2016
Table Mylan Pharmaceuticals, Inc, Prescription Dermatological Drug SWOT Analysis
Table Novartis Pharmaceuticals Corporation Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prescription Dermatological Drug Picture and Specifications of Novartis Pharmaceuticals Corporation
Table Prescription Dermatological Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Novartis Pharmaceuticals Corporation 2011-2016
Figure Prescription Dermatological Drug Capacity (Unit), Production (Unit) and Growth Rate of Novartis Pharmaceuticals Corporation 2011-2016
Figure Prescription Dermatological Drug Production (Unit) and United States Market Share of Novartis Pharmaceuticals Corporation 2011-2016
Table Novartis Pharmaceuticals Corporation Prescription Dermatological Drug SWOT Analysis
Table Nycomed Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prescription Dermatological Drug Picture and Specifications of Nycomed Inc.
Table Prescription Dermatological Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Nycomed Inc. 2011-2016
Figure Prescription Dermatological Drug Capacity (Unit), Production (Unit) and Growth Rate of Nycomed Inc. 2011-2016
Figure Prescription Dermatological Drug Production (Unit) and United States Market Share of Nycomed Inc. 2011-2016
Table Nycomed Inc. Prescription Dermatological Drug SWOT Analysis
Table Pfizer, Inc. Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Prescription Dermatological Drug Picture and Specifications of Pfizer, Inc.
Table Prescription Dermatological Drug Capacity (Unit), Production (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer, Inc. 2011-2016
Figure Prescription Dermatological Drug Capacity (Unit), Production (Unit) and Growth Rate of Pfizer, Inc. 2011-2016
Figure Prescription Dermatological Drug Production (Unit) and United States Market Share of Pfizer, Inc. 2011-2016
Table Pfizer, Inc. Prescription Dermatological Drug SWOT Analysis
Table Prescription Dermatological Drug Price by Regions 2011-2016
Table Prescription Dermatological Drug Price by Product Types 2011-2016
Table Prescription Dermatological Drug Price by Companies 2011-2016
Table Prescription Dermatological Drug Gross Margin by Companies 2011-2016
Table Price Comparison of Prescription Dermatological Drug by Regions 2011-2016 (USD/Unit)
Table Price of Different Prescription Dermatological Drug Product Types (USD/Unit)
Table Market Share of Different Prescription Dermatological Drug Price Level
Table Gross Margin of Different Prescription Dermatological Drug Applications
Table Marketing Channels Status of Prescription Dermatological Drug
Table Traders or Distributors of Prescription Dermatological Drug with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Prescription Dermatological Drug (USD/Unit) in 2015
Table United States Import, Export, and Trade of Prescription Dermatological Drug (Unit)
Figure United States Capacity (Unit), Production (Unit) and Growth Rate of Prescription Dermatological Drug 2016-2021
Figure United States Capacity Utilization Rate of Prescription Dermatological Drug 2016-2021
Table United States Prescription Dermatological Drug Production by Type 2016-2021 (Unit)
Table United States Prescription Dermatological Drug Production Market Share by Type 2016-2021
Figure United States Production Market Share of Prescription Dermatological Drug by Type in 2021
Figure United States Sales (Unit) and Growth Rate of Prescription Dermatological Drug 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Prescription Dermatological Drug 2016-2021
Figure United States Sales of Prescription Dermatological Drug by Applications 2016-2021 (Unit)
Table United States Production Market Share of Prescription Dermatological Drug by Applications 2016-2021
Figure United States Production Market Share of Prescription Dermatological Drug by Applications in 2021
Table United States Production, Import, Export and Consumption of Prescription Dermatological Drug 2016-2021 (Unit)
Table United States Production (Unit), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Prescription Dermatological Drug 2016-2021
Table Major Raw Materials Suppliers of Prescription Dermatological Drug with Contact Information
Table Manufacturing Equipment Suppliers of Prescription Dermatological Drug with Contact Information
Table Major Players of Prescription Dermatological Drug with Contact Information
Table Key Consumers of Prescription Dermatological Drug with Contact Information
Table Supply Chain Relationship Analysis of Prescription Dermatological Drug
Table New Project SWOT Analysis of Prescription Dermatological Drug
Table New Project Investment Feasibility Analysis of Prescription Dermatological Drug
Table Part of Interviewees Record List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
